Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 114.00
-1.60 (-1.38%)
Oct 28, 2025, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 105.01 billion as of October 29, 2025. Its market cap has increased by 69.86% in one year.
Market Cap
105.01B
Enterprise Value
102.07B
Revenue
2.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
114.00
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 105.01B, an increase of 466.27%. That is a compound annual growth rate of 36.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 105.01B | 92.74% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.73B |
| Hansoh Pharmaceutical Group Company | 209.22B |
| JD Health International | 201.53B |
| WuXi Biologics | 149.43B |
| Innovent Biologics | 144.96B |
| Sino Biopharmaceutical | 126.75B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.36B |
| Alibaba Health Information Technology | 97.49B |